Myeloid malignancies like AML, MDS, and CML generally showed higher TGFB1 expression when compared to normal samples and the opposite was seen in lymphoid leukemias (ALL and CLL) (Fig. 2A). Here, TGFB1 is linked to acute lymphoblastic leukemia.